Investigator
Senior Computational Biologist I · Sloan Kettering Institute, Sohrab shah research
Ongoing genome doubling shapes evolvability and immunity in ovarian cancer
Single-cell whole-genome sequencing of 30,260 tumour genomes from 70 samples across 41 patients in the SPECTRUM cohort reveals that ongoing whole-genome doubling drives tumour evolvability and immune evasion in high-grade serous ovarian cancer.
Tracking clonal evolution during treatment in ovarian cancer using cell-free DNA
Emergence of drug resistance is the main cause of therapeutic failure in patients with high-grade serous ovarian cancer (HGSOC)
Senior Computational Biologist I
Sloan Kettering Institute · Sohrab shah research
US
